SOURCE: Igantia Therapeutics

Igantia Therapeutics

April 16, 2015 13:27 ET

Igantia Therapeutics Partners With Fogarty Institute of Innovation

SAN FRANCISCO, CA--(Marketwired - Apr 16, 2015) - Igantia Therapeutics, a women's health and research company, was recently admitted to the 501(c)(3) non-profit Fogarty Institute for Innovation. The Institute carefully selects and invites exceptionally innovative and important start-up companies to reside at the Institute where they are provided with support as they transform their ideas into revolutionary medical technologies that will help patients. Igantia was selected for its plan to revolutionize the women's health industry by developing a first of its kind medical device technology for the treatment and study of an age related ailment that effects virtually all women -- hot flashes. 

With the support of the Fogarty Institute's world class mentors, the company will work to receive proof-of-concept validation to assist in securing funding and awarded grants. "It was truly an honor to accept an accolade of this caliber during the fundamental stages of building the company," stated Igantia founder, Dr. Sohila Zadran. "With the support of the Fogarty Institute and access to their network of physicians, Igantia truly has the opportunity to transform the women's health industry and the way that we understand aging as a whole."

About Igantia Therapeutics
Igantia Therapeutics, a female owned research and biotechnology company, is leading the very first global initiative to better understand aging in women, in real time. With a mission of understanding human aging, Igantia believes that we must first better understand the inherent biological clocks of women. Having two major divisions and supporting a women's health movement, Igantia produces innovations to revolutionize the healthcare industry, specifically for women.

Contact Information